Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/30391
Title: | Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-resolution Computed Tomography. | Austin Authors: | Walsh, Simon Lf;Mackintosh, John A;Calandriello, Lucio;Silva, Mario;Sverzellati, Nicola;Larici, Anna Rita;Humphries, Stephen M;Lynch, David A;Jo, Helen E;Glaspole, Ian;Grainge, Christopher;Goh, Nicole S L ;Hopkins, Peter M A;Moodley, Yuben;Reynolds, Paul N;Zappala, Christopher;Keir, Gregory;Cooper, Wendy A;Mahar, Annabelle M;Ellis, Samantha;Wells, Athol U;Corte, Tamera J | Affiliation: | Alfred Health, 5392, Department of Radiology, Melbourne, Victoria, Australia.. Royal Prince Alfred Hospital, 2205, Department of Respiratory and Sleep Medicine, Camperdown, New South Wales, Australia.. Respiratory and Sleep Medicine Alfred Health, 5392, Allergy, Immunology & Respiratory Medicine Department, Melbourne, Victoria, Australia.. The Prince Charles Hospital, 67567, Chermside, Queensland, Australia.. The University of Western Australia, Respiratory Medicine, Perth, Western Australia, Australia.. Royal Adelaide Hospital, Thoracic Medicine, Adelaide, South Australia.. The University of Queensland, 1974, Saint Lucia, Queensland, Australia.. Princess Alexandra Hospital, Brisbane, Queensland, Australia.. Royal Prince Alfred Hospital, 2205, Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Camperdown, New South Wales, Australia.. Imperial College London, 4615, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.. The Alfred Hospital, Melbourne, Australia.. Monash University, Melbourne, Australia.. John Hunter Hospital, 37024, New Lambton Heights, New South Wales, Australia.. The Prince Charles Hospital, Brisbane, Queensland, Australia.. Centre of Research Excellence in Pulmonary Fibrosis, Camperdown , New South Wales, Australia.. The University of Sydney, 4334, Sydney, New South Wales, Australia.. Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 18654, Dipartimento di Diagnostica per immagini, Roma, Italy.. Universita degli Studi di Parma, 9370, Section of Radiology, Department of Medicine and Surgery, Parma, Italy.. Department of Surgical Sciences, Ospedale Maggiore di Parma, Parma, Italy.. National Jewish Health, 2930, Denver, Colorado, United States.. National Jewish Health, Radiology, Denver, Colorado, United States.. Royal Brompton Hospital, Interstitial Lung Disease Unit, London, United Kingdom of Great Britain and Northern Ireland.. Institute for Breathing and Sleep |
Issue Date: | 13-Jun-2022 | Date: | 2022 | Publication information: | American Journal of Respiratory and Critical Care Medicine 20221; 206(7): 883-891 | Abstract: | RATIONALE Reliable outcome prediction in patients with fibrotic lung disease using baseline high-resolution computed tomography (HRCT) data remains challenging. OBJECTIVES To evaluate the prognostic accuracy of a deep learning algorithm (SOFIA), trained and validated in the identification of UIP-like features on HRCT (UIP probability), in a large cohort of well characterised patients with progressive fibrotic lung disease, drawn from a national registry. METHODS SOFIA and radiologist-UIP probabilities were converted to PIOPED-based UIP probability categories (UIP not included in the differential: 0-4%, low probability of UIP: 5-29%, intermediate probability of UIP: 30-69%, high probability of UIP: 70-94%, and pathognomonic for UIP:95-100%) and their prognostic utility assessed using Cox proportional hazards modelling. MEASUREMENTS AND MAIN RESULTS On multivariable analysis adjusting for age, gender, guideline based radiologic diagnosis and disease severity (using total ILD extent on HRCT, %predicted FVC, DLco or the CPI), only SOFIA-UIP probability PIOPED categories predicted survival. SOFIA-PIOPED UIP probability categories remained prognostically significant in patients considered indeterminate (n=83) by expert radiologist consensus (HR1.73, p<0.0001, 95%CI 1.40-2.14). In patients undergoing surgical lung biopsy (SLB) (n=86), after adjusting for guideline-based histologic pattern and total ILD extent on HRCT, only SOFIA-PIOPED probabilities were predictive of mortality (HR1.75, p<0.0001, 95%CI 1.37-2.25). CONCLUSIONS Deep learning-based UIP probability on HRCT provides enhanced outcome prediction in patients with progressive fibrotic lung disease when compared to expert radiologist evaluation or guideline-based histologic pattern. In principle this tool may be useful in multidisciplinary characterisation of fibrotic lung disease. The utility of this technology as a decision support system when ILD expertise is unavailable requires further investigation. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/30391 | DOI: | 10.1164/rccm.202112-2684OC | ORCID: | 0000-0002-2538-7032 0000-0002-5113-4530 0000-0003-2065-4346 |
Journal: | American journal of respiratory and critical care medicine | PubMed URL: | 35696341 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35696341/ | Type: | Journal Article | Subjects: | Deep learning Idiopathic pulmonary fibrosis Interstitial lung disease Radiology Usual interstitial pneumonia |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.